Faria, A.V.S.; Andrade, S.S.; Reijm, A.N.; Spaander, M.C.W.; de Maat, M.P.M.; Peppelenbosch, M.P.; Ferreira-Halder, C.V.; Fuhler, G.M.
Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936.
https://doi.org/10.3390/jcm8070936
AMA Style
Faria AVS, Andrade SS, Reijm AN, Spaander MCW, de Maat MPM, Peppelenbosch MP, Ferreira-Halder CV, Fuhler GM.
Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. Journal of Clinical Medicine. 2019; 8(7):936.
https://doi.org/10.3390/jcm8070936
Chicago/Turabian Style
Faria, Alessandra V. S., Sheila S. Andrade, Agnes N. Reijm, Manon C. W. Spaander, Moniek P. M. de Maat, Maikel P. Peppelenbosch, Carmen V. Ferreira-Halder, and Gwenny M. Fuhler.
2019. "Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients" Journal of Clinical Medicine 8, no. 7: 936.
https://doi.org/10.3390/jcm8070936
APA Style
Faria, A. V. S., Andrade, S. S., Reijm, A. N., Spaander, M. C. W., de Maat, M. P. M., Peppelenbosch, M. P., Ferreira-Halder, C. V., & Fuhler, G. M.
(2019). Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. Journal of Clinical Medicine, 8(7), 936.
https://doi.org/10.3390/jcm8070936